By Herbert Lash NEW YORK (Reuters) – Canada’s Valeant Pharmaceuticals International Inc VRX.TO VRX.N agreed to acquire gastrointestinal drugmaker Salix Pharmaceuticals Ltd SLXP.O in an all-cash deal valued at about $10.1 billion, the two companies said on Sunday. The deal for Salix, kno…
Source:Canada’s Valeant to acquire Salix in $10.1 billion deal
Sunday, February 22, 2015
Canada’s Valeant to acquire Salix in $10.1 billion deal
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment